Shame there is some salty ex holders trying to push their uneducated opinion on to new investors. Most people have enjoyed the run from 2.6c up to 7+ hardly ill informed it would appear.
"Successful study results would mean a key breakthrough for MGC Pharma in the treatment of
aggressive brain cancers, one of its key target clinical research treatment areas – Oncology"
These guys have a lot of products that could be game changers, once in a lifetime stuff.
Now that the Options are in the money(exercise price 4.5c expiry August 31 2021) it is more likely they will be exercised which would put $3.8 mil into MXC bank account. Last I heard they had $1.4mil in the bank as well (3oth Sep 2020) This suggests no cash flow problem to me.
Good luck long term holders, this is a very exciting stock to be apart of!
- Forums
- ASX - By Stock
- RGT
- MGC Pharmaceuticals (ASX:MXC) appoints Nicole Godresse as Global Chief Sales Officer
MGC Pharmaceuticals (ASX:MXC) appoints Nicole Godresse as Global Chief Sales Officer, page-8
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
53.0¢ |
Change
0.180(51.4%) |
Mkt cap ! $25.65M |
Open | High | Low | Value | Volume |
38.0¢ | 56.0¢ | 38.0¢ | $71.38K | 137.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 334 | 51.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.0¢ | 60 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 334 | 0.510 |
1 | 680 | 0.470 |
1 | 2000 | 0.460 |
1 | 5000 | 0.450 |
2 | 9000 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.550 | 60 | 1 |
0.590 | 2000 | 1 |
0.620 | 1414 | 1 |
0.700 | 1368 | 1 |
0.740 | 350 | 1 |
Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online